Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-06 Sale | 2024-03-07 4:46 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 126,981 | $5.6 | $711,094 | 1,522,114 (Direct) | View |
| 2023-03-02 Sale(A) | 2024-02-22 4:15 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 33,047 | $8.78 | $290,153 | 982,671 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:27 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 32,750 | $8.94 | $292,785 | 982,968 (Direct) | View |
| 2022-03-02 Sale | 2022-03-04 4:11 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 9,068 | $12.01 | $108,907 | 879,395 (Direct) | View |
| 2021-05-11 Purchase | 2021-05-12 4:32 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 5,125 | $10.71 | $54,891 | 13,453 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-20 Option Award | 2024-02-22 4:25 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 661,538 | $0 | 1,649,095 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:27 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 667,407 | $0 | 982,968 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:22 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 173,517 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:22 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 79,645 | $5.6 | 0 (Direct) | View |
| 2022-03-22 Other | 2022-03-22 5:12 pm | N/A N/A | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 105,034 | $0 | 105,034 (Direct) | View |
| 2022-03-22 Disposition | 2022-03-22 5:12 pm | N/A N/A | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 206,257 | $0 | 105,034 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 4:11 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 874,728 | $0 | 879,395 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 6:02 pm | N/A 2023-01-27 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 20,492 | $0 | 250,119 (Direct) | View |
| 2022-01-27 Exercise | 2022-01-31 6:02 pm | N/A 2023-01-27 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 10,246 | $0 | 250,119 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 6:02 pm | N/A 2032-01-26 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 114,347 | $3.66 | 250,119 (Direct) | View |
| 2021-08-06 Exercise | 2021-08-10 6:17 pm | N/A 2022-08-01 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 35,000 | $0 | 112,288 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:22 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 48,542 | $0 | 128,187 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:22 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 25,452 | $4.42 | 128,187 (Direct) | View |
Ownership | 2021-01-04 5:53 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 0 | $0 | 2,838,128 (Direct) | View |
| 2020-08-07 Exercise | 2020-08-11 5:03 pm | N/A 2022-08-01 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 35,000 | $0 | 112,288 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 7:02 pm | N/A 2030-06-11 | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 58,246 | $0 | 112,439 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 7:02 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 30,220 | $2.73 | 112,439 (Direct) | View |
| 2019-08-07 Option Award | 2019-10-03 4:40 pm | N/A 2029-08-07 | Cerecor Inc. | CERC | Greenleaf Peter Director | 25,000 | $0 | 297,988 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-15 4:25 pm | N/A 2022-08-01 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Greenleaf Peter Director | 21,144 | $0 | 112,288 (Direct) | View |
| 2019-06-13 Option Award | 2019-06-14 5:49 pm | N/A 2029-06-13 | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 46,729 | $0 | 70,702 (Direct) | View |
| 2019-06-13 Option Award | 2019-06-14 5:49 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 23,973 | $2.92 | 70,702 (Direct) | View |
| 2019-05-24 Disposition | 2019-05-29 4:29 pm | N/A 2029-04-01 | Cerecor Inc. | CERC | Greenleaf Peter Director | 1,489,583 | $0 | 272,988 (Direct) | View |